These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 31693292

  • 1. Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Russo JJ, Prasad M, Doshi D, Karmpaliotis D, Parikh MA, Ali ZA, Popma JJ, Pershad A, Ohman EM, Douglas PS, O'Neill WW, Leon MB, Moses JW, Kirtane AJ.
    Catheter Cardiovasc Interv; 2020 Oct 01; 96(4):764-770. PubMed ID: 31693292
    [Abstract] [Full Text] [Related]

  • 2. Hemodynamically supported percutaneous coronary revascularization improves left ventricular function in patients with ischemic dilated cardiomyopathy at very high risk for surgery: a single-center experience.
    Gimelli G, Wolff MR.
    J Invasive Cardiol; 2008 Dec 01; 20(12):642-6. PubMed ID: 19057027
    [Abstract] [Full Text] [Related]

  • 3. Health Status Benefits of Successful Chronic Total Occlusion Revascularization Across the Spectrum of Left Ventricular Function: Insights From the OPEN-CTO Registry.
    Khariton Y, Airhart S, Salisbury AC, Spertus JA, Gosch KL, Grantham JA, Karmpaliotis D, Moses JW, Nicholson WJ, Cohen DJ, Lombardi W, Sapontis J, McCabe JM.
    JACC Cardiovasc Interv; 2018 Nov 26; 11(22):2276-2283. PubMed ID: 30466826
    [Abstract] [Full Text] [Related]

  • 4. Angiographic Characteristics and Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the cVAD PROTECT III Study.
    Bharadwaj AS, Abu-Much A, Maini AS, Zhou Z, Li Y, Batchelor WB, Grines CL, Baron SJ, Redfors B, Lansky AJ, Basir MB, O'Neill WW.
    Circ Cardiovasc Interv; 2024 Jul 26; 17(7):e013503. PubMed ID: 38708609
    [Abstract] [Full Text] [Related]

  • 5. Right Ventricular Function in Peripartum Cardiomyopathy at Presentation Is Associated With Subsequent Left Ventricular Recovery and Clinical Outcomes.
    Blauwet LA, Delgado-Montero A, Ryo K, Marek JJ, Alharethi R, Mather PJ, Modi K, Sheppard R, Thohan V, Pisarcik J, McNamara DM, Gorcsan J, IPAC Investigators*.
    Circ Heart Fail; 2016 May 26; 9(5):. PubMed ID: 27166247
    [Abstract] [Full Text] [Related]

  • 6. Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?
    Schinkel AF, Poldermans D, Rizzello V, Vanoverschelde JL, Elhendy A, Boersma E, Roelandt JR, Bax JJ.
    J Thorac Cardiovasc Surg; 2004 Feb 26; 127(2):385-90. PubMed ID: 14762345
    [Abstract] [Full Text] [Related]

  • 7. The Role of Mechanical Circulatory Support During Percutaneous Coronary Intervention in Patients Without Severely Depressed Left Ventricular Function.
    Alaswad K, Basir MB, Khandelwal A, Schreiber T, Lombardi W, O'Neill W.
    Am J Cardiol; 2018 Mar 15; 121(6):703-708. PubMed ID: 29370923
    [Abstract] [Full Text] [Related]

  • 8. Impella-assisted chronic total occlusion percutaneous coronary interventions: A multicenter retrospective analysis.
    Riley RF, McCabe JM, Kalra S, Lazkani M, Pershad A, Doshi D, Kirtane AJ, Nicholson W, Kearney K, Demartini T, Aaron Grantham J, Moses J, Lombardi W, Karmpaliotis D.
    Catheter Cardiovasc Interv; 2018 Dec 01; 92(7):1261-1267. PubMed ID: 30019817
    [Abstract] [Full Text] [Related]

  • 9. Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry).
    Shavelle DM, Banerjee S, Maini B, Schreiber TL, Kapasi N, O'Neill WW, Popma J, Matthews RV.
    Am J Cardiol; 2018 Sep 15; 122(6):966-972. PubMed ID: 30057231
    [Abstract] [Full Text] [Related]

  • 10. Impact of guideline-recommended versus non-guideline-recommended β-blocker and Doppler echocardiographic parameters on 1-year mortality in Thai ischemic cardiomyopathy patients: A prospective multicenter registry.
    Wongpraparut N, Siwamogsatham S, Thongsri T, Ngamjanyaporn P, Phrommintikul A, Jirajarus K, Tangcharoen T, Bhumimuang K, Kaewsuwanna P, Krittayaphong R, Pongakasira R, White HD.
    BMC Cardiovasc Disord; 2020 Jan 09; 20(1):8. PubMed ID: 31918676
    [Abstract] [Full Text] [Related]

  • 11. Impact of Impella protected-percutaneous coronary intervention on left ventricle function recovery of patients with extensive coronary disease and poor left ventricular function.
    Romagnoli E, Burzotta F, Cerracchio E, Russo G, Aurigemma C, Pedicino D, Locorotondo G, Graziani F, Leone AM, D'Amario D, Lombardo A, Malara S, Fulco L, Bianchini F, Sanna T, Trani C.
    Int J Cardiol; 2023 Sep 15; 387():131098. PubMed ID: 37290663
    [Abstract] [Full Text] [Related]

  • 12. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B, Naidu SS, Mulukutla S, Kleiman N, Schreiber T, Wohns D, Dixon S, Rihal C, Dave R, O'Neill W.
    Catheter Cardiovasc Interv; 2012 Nov 01; 80(5):717-25. PubMed ID: 22105829
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term mortality data from the balloon pump-assisted coronary intervention study (BCIS-1): a randomized, controlled trial of elective balloon counterpulsation during high-risk percutaneous coronary intervention.
    Perera D, Stables R, Clayton T, De Silva K, Lumley M, Clack L, Thomas M, Redwood S, BCIS-1 Investigators.
    Circulation; 2013 Jan 15; 127(2):207-12. PubMed ID: 23224207
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A, Kimura T, Nishiwaki N, Mitsudo K, Komiya T, Hanyu M, Shiomi H, Tanaka S, Sakata R, CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.
    Am J Cardiol; 2014 Oct 01; 114(7):988-96. PubMed ID: 25124184
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.
    Gioia G, Matthai W, Gillin K, Dralle J, Benassi A, Gioia MF, White J.
    Catheter Cardiovasc Interv; 2007 Jul 01; 70(1):26-33. PubMed ID: 17585381
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcomes in patients undergoing complex, high-risk percutaneous coronary intervention and haemodynamic support with intra-aortic balloon versus Impella pump: Real-life single-centre preliminary results.
    Januszek R, Pawlik A, Rzeszutko Ł, Bartuś K, Bartuś S.
    Kardiol Pol; 2022 Jul 01; 80(12):1224-1231. PubMed ID: 36047958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.